Phosphodiesterase 5 inhibitor sildenafil in patients with heart failure with preserved ejection fraction and combined pre- and postcapillary pulmonary hypertension: a randomized open-label pilot study.
Evgeny BelyavskiyArtem OvchinnikovAlexandra PotekhinaFail AgeevFrank EdelmannPublished in: BMC cardiovascular disorders (2020)
Russian National Information System of Research, Development and Technology Data of Civilian Usage (NIS, https://rosrid.ru), registration number 01201257849 . Registered 20 April 2012. This manuscript adheres to the CONSORT guidelines.
Keyphrases
- pulmonary hypertension
- open label
- pulmonary artery
- pulmonary arterial hypertension
- electronic health record
- clinical trial
- quality improvement
- clinical practice
- phase ii
- phase iii
- big data
- study protocol
- phase ii study
- health information
- healthcare
- randomized controlled trial
- squamous cell carcinoma
- data analysis
- coronary artery
- social media